- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Case Reports in Dentistry
Volume 2013 (2013), Article ID 402096, 5 pages
Clinical Management of Suppurative Osteomyelitis, Bisphosphonate-Related Osteonecrosis, and Osteoradionecrosis: Report of Three Cases and Review of the Literature
1Department of Clinic and Surgery, School of Dentistry, Federal University of Alfenas, 37130-000 Alfenas, MG, Brazil
2Oral Pathology, College of Dental Medicine-Illinois, Midwestern University, Downers Grove, IL 60515, USA
3Oral Pathology, Department of Biomedical Sciences, Federal University of Alfenas, 37130-000 Alfenas, MG, Brazil
4Stomatology, Department of Clinic and Surgery, School of Dentistry, Federal University of Alfenas, 37130-000 Alfenas, MG, Brazil
Received 26 August 2013; Accepted 23 September 2013
Academic Editors: N. H. Rohleder and C.-H. Wu
Copyright © 2013 Eduardo Pereira Guimarães et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
In the past, osteomyelitis was frequent and characterized by a prolonged course, treatment response uncertainty, and occasional disfigurement. Today, the disease is less common; it is believed that the decline in prevalence may be attributed to increased availability of antibiotics and improvement of overall health patterns. Currently, more common osteomyelitis variants are seen, namely, osteoradionecrosis (ORN) and bisphosphonate-related osteonecrosis of the jaws (BRONJ). Osteomyelitis, ORN, and BRONJ can present with similar symptoms, signs, and radiographic findings. However, each condition is a separate entity, with different treatment approaches. Thus, accurate diagnosis is essential for adequate management and improved patient prognosis. The aim of this paper is to report three cases of inflammatory lesions of the jaws—osteomyelitis, ORN, and BRONJ—and to discuss their etiology, clinical aspects, radiographic findings, histopathological features, treatment options, and preventive measures.
The osteomyelitis is an inflammatory condition of the bone, which generally begins as an infection of the marrow cavity, rapidly involves the Haversian canals, and eventually extends to the periosteum . In the past, osteomyelitis was frequent and characterized by a prolonged course, treatment response uncertainty, and occasional disfigurement (due to loss of bone and teeth and resulting facial scars). Today, the disease is less common, and it is believed that the decline in prevalence may be attributed to the increased availability of antibiotics and improvement of overall health patterns . Nonetheless, osteomyelitis remains a challenging disease for both clinicians and patients.
Currently, more common osteomyelitis variants are seen. ORN is one of the most serious complications in the treatment of head and neck malignancies and is defined as the ischemic necrosis of the irradiated bone, which becomes hypovascular, hypocellular, and hypoxic [3, 4]. BRONJ is one of the more recently reported serious adverse effects of bisphosphonates treatment, which are used to manage oncologic patients and to prevent fractures in osteoporosis [5, 6].
Osteomyelitis, ORN, and BRONJ can present with similar symptoms, signs, and radiographic findings. However, each condition is a separate entity, with different management approaches . Thus, the aim of this paper is to report three cases of inflammatory lesions of the jaws—osteomyelitis, ORN, and BRONJ—and to discuss their etiology, clinical aspects, radiographic findings, histopathological features, treatment options, and preventive measures. Written informed consent was obtained from all the patients.
2. Case Reports
Case 1. A 77-year-old white female was seen at the Oral Medicine Clinic of the Federal University of Alfenas (UNIFAL-MG) with an asymptomatic, smooth surfaced, normal colored tumor on the anterior mandibular alveolar ridge, with two months evolution. A drainage point with purulent material was also present (Figure 1(a)). The patient’s medical history was unremarkable and no changes were noted on extraoral examination. Radiographic examination revealed osteolysis and bone sequestration on the mandibular alveolar ridge (Figure 1(b)). Based on clinical and radiographic findings, a provisional diagnosis of osteomyelitis was rendered. The patient was given amoxicillin (500 mg, three times/day) for 15 days and subsequently underwent excision of the bone sequestrum and curettage of the granulation tissue (Figure 2). The material was submitted to histopathological examination which revealed nonviable bone and a mixed inflammatory infiltrate of lymphocytes and plasma cells, confirming the diagnosis of chronic suppurative osteomyelitis. The area healed appropriately within one month (Figures 3(a) and 3(b)). The patient has been under follow-up for 5 years with no signs of recurrence.
Case 2. A 46-year-old male was seen at the Oral Medicine Clinic of the UNIFAL-MG with chief complaint of pain in the area of tooth no. 20. Medical history revealed a history of oral squamous cell carcinoma 15 months before. The cancer had been treated with 40 sessions of radiotherapy and 7 cycles of chemotherapy six months before. No surgical treatment and preradiotherapy dental assessment had been performed. A history of tobacco and alcohol use was also reported. Clinical examination showed splinting of anterior teeth due to periodontal disease, absence of teeth, and generalized radiation caries. Radiographic examination showed generalized bone loss. In view of the patient’s unsatisfactory oral condition and due to the short period since the end of radiotherapy, a conservative approach was instituted. Preventive and restorative procedures were executed for oral health establishment. Subsequently, no. 28 and the anterior incisors, presenting extensive carious lesions with periapical involvement, were extracted under antibiotic therapy (500 mg amoxicillin, three times a day, for 10 days). After 15 days, the extraction site in the region of no. 28 failed to heal appropriately. Thus, irrigation with sodium iodide and chlorhexidine, as well as surgical debridement, was instituted. After 7 days, no improvement was noted; clinical examination revealed an ulcer with an erythematous halo and a serofibrinous pseudomembrane (Figure 4(a)). The underlying cortical bone was exposed and necrotic, and intense pain was reported. A diagnosis of ORN was established and the patient was submitted to segmental osteotomy of the involved region. At this moment, the patient showed no signs of lesion recurrence or any residual tumor. Unfortunately, primary closure was not obtained and the patient eventually developed a pathological fracture within one year (Figure 4(b)). A few months later, the patient succumbed to hepatic metastases.
Case 3. A 51-year-old female was referred for evaluation of a submental fistula with purulent drainage, with evolution of 7 days (Figure 5(a)). Medical history revealed breast cancer and use of pamidronate (90 mg) for the past two years. Clinical exam showed absence of all teeth and normal mucosa. No radiographic changes were observed (Figure 5(b)). Based on clinical history and findings, the diagnostic hypothesis was BRONJ. The purulent material was collected and cultured, and revealed the presence of Staphylococcus epidermidis with sensitivity to clindamycin. Based on microbiological analysis, the patient was administered 300 mg oral clindamycin for 35 days, and the use of pamidronate was discontinued. Following this period, fistula closure was observed, along with absence of drainage. The patient is currently being followed up with no signs of recurrence.
Osteomyelitis, ORN, and BRONJ are all, in general, more common in the mandible (angle and body) than in the maxilla. This likely occurs due to the mandible’s increased density and less vascularized cortical plates. Also, in contrast to the maxilla, the mandible has only a single blood supply source, from the inferior alveolar neurovascular bundle [8, 9]. In agreement with the literature [10, 11], all of our cases developed in the mandible.
Local and systemic host factors are key in understanding the pathogenesis of osteomyelitis . The cause of osteomyelitis is predominantly odontogenic (dental-infection related) or traumatic (fracture related) in nature. In most cases, the primary complaints are swelling, pain, or draining fistula. Other initial signs include pathologic fracture, malocclusion, sequestra, and exposed bone, fever, and trismus . A wide range of organisms contributes to chronic osteomyelitis . No specific microorganism is found to be a predominant etiologic agent for osteomyelitis . The distinction between acute and chronic osteomyelitis is based on evolution; an acute process develops up to one month after appearance of the symptoms, while a chronic process takes longer than one month [13, 14]. Case 1 evolved for 2 months, characterizing chronic osteomyelitis. The most common findings of osteomyelitis are diffuse sclerosis, a peripheral sclerotic rim, cortical layering (involucrum), central loss of trabecular pattern with internal round radiolucent resorptive tracts, minimal jaw expansion, and reduction of the alveolar cortex on radiographic examination [8, 11], features which were also presents in our case.
The pathogenesis of ORN has not yet been fully elucidated. It is thought that radiation-generated free radicals and corresponding damage to endothelial cells lead to hypovascularity, tissue hypoxia, destruction of bone-forming cells, and marrow fibrosis . Radiation may also suppress bone turnover via osteoclasis . In addition, anaerobic bacteria may play a fundamental role in the pathogenesis of ORN . The incidence of ORN in patients varies from 0.4% to 56% , but it has declined in recent decades . Such decrease in presumably is due to the advent of megavoltage RT and to the increased awareness of the importance of oral health care .
ORN is typically associated with surgical extractions, which should ideally be performed 21 days before initiation of RT . If absolutely necessary, post-RT extractions should be performed with minimal trauma and under antibiotic therapy. In Case 2, the patient was only seen after RT. Because no pretherapy oral treatment was instituted, post-RT surgical intervention was required. This was probably a key factor in the development of the ORN [17, 18].
Bisphosphonates are primarily effectively employed in neoplasia-related conditions, such as malignant hypercalcemia, bony metastasis, and lytic lesions of multiple myelomas . Among bisphosphonates, zoledronic acid and pamidronate are most commonly employed. In addition, alendronate, risedronate, and ibandronate are frequently used for osteoporosis . ONJ may occur due to enzymatic inhibition, which leads to cell toxicity induced by the medication. Patients that use intravenous bisphosphonates are more susceptible to BRONJ than those that take the medication orally. Systemic factors, such as diabetes, immunosuppression, and concomitant use of other drugs may also be involved with the development of BRONJ . Most cases of BRONJ occur following extractions. Occasionally, BRONJ may spontaneously develop , such as in the current case. No oral infectious foci, exposed areas, or radiographic findings were present.
Surgical therapy in association with antibiotics and anti-inflammatory drugs has been shown to be beneficial for patients with all three types of disease, with significant improvement in quality of life. Still, exacerbations may occur and regular follow-up is necessary [23–25]. In our study, two patients underwent surgical intervention for their disease. Although patient 1 evolved to cure, patient 2 developed a pathological fracture in the ORN region, highlighting that the clinical picture may exacerbate even with surgical intervention . Patient 3 was managed with medications only, without the necessity for surgical intervention. Hyperbaric oxygen and platelet-rich plasma have been recommended for the treatment of both ORN and BRONJ. However, the benefits of these therapies are inconsistent in the literature [25, 27–30].
Bone inflammatory diseases are important due to high morbidity and mortality rates. Even with a decline in traditional osteomyelitis, ORN and BRONJ have emerged as important secondary consequences of commonly used therapeutics. Osteomyelitis, ORN, and BRONJ may present with similar sign and symptoms; thus, it is crucial for oral health professionals to differentiate between these processes. A correct diagnosis will allow adequate management and improve patients’ prognosis. Dentists also play an important role in preventing damage, by providing pretherapy care aiming to eliminate compromising or infectious foci.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
The authors wish to thank FAPEMIG (Fundação de Amparo à Pesquisa do Estado de Minas Gerais) for supporting this study.
- M. Baltensperger and G. Eyrich, Osteomyelitis of the Jaws, Springer, Berlin, Germany, 2008.
- S. C. Yeoh, S. MacMahon, and M. Schifter, “Chronic suppurative osteomyelitis of the mandible: case report,” Australian Dental Journal, vol. 50, no. 3, pp. 200–203, 2005.
- J. J. Sciubba and D. Goldenberg, “Oral complications of radiotherapy,” The Lancet Oncology, vol. 7, no. 2, pp. 175–183, 2006.
- M. S. Teng and N. D. Futran, “Osteoradionecrosis of the mandible,” Current Opinion in Otolaryngology and Head and Neck Surgery, vol. 13, no. 4, pp. 217–221, 2005.
- S. L. Ruggiero, “Bisphosphonate-related osteonecrosis of the jaw (BRONJ): initial discovery and subsequent development,” Journal of Oral and Maxillofacial Surgery, vol. 67, no. 5, supplement, pp. 13–18, 2009.
- C. A. Migliorati, S. B. Woo, I. Hewson et al., “A systematic review of bisphosphonate osteonecrosis (BON) in cancer,” Supportive Care in Cancer, vol. 18, no. 8, pp. 1099–1106, 2010.
- R. E. Marx and R. Tursun, “Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease,” International Journal of Oral and Maxillofacial Surgery, vol. 41, no. 3, pp. 283–289, 2012.
- J. M. Fullmer, W. C. Scarfe, G. M. Kushner, B. Alpert, and A. G. Farman, “Cone beam computed tomographic findings in refractory chronic suppurative osteomyelitis of the mandible,” British Journal of Oral and Maxillofacial Surgery, vol. 45, no. 5, pp. 364–371, 2007.
- G. F. Koorbusch, P. Fotos, and K. T. Goll, “Retrospective assessment of osteomyelitis. Etiology, demographics, risk factors, and management in 35 cases,” Oral Surgery Oral Medicine and Oral Pathology, vol. 74, no. 2, pp. 149–154, 1992.
- C. R. Bevin, C. Y. Inwards, and E. E. Keller, “Surgical management of primary chronic osteomyelitis: a long-term retrospective analysis,” Journal of Oral and Maxillofacial Surgery, vol. 66, no. 10, pp. 2073–2085, 2008.
- P. Frid, K. Tornes, Ø. Nielsen, and N. Skaug, “Primary chronic osteomyelitis of the jaw—a microbial investigation using cultivation and DNA analysis: a pilot study,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 107, no. 5, pp. 641–647, 2009.
- V. Coviello and M. R. Stevens, “Contemporary concepts in the treatment of chronic osteomyelitis,” Oral and Maxillofacial Surgery Clinics of North America, vol. 19, no. 4, pp. 523–534, 2007.
- R. E. Marx, “Chronic osteomyelitis of the jaws,” in Oral and Maxillofacial Surgery Clinics of North America, D. Laskin and R. Strass, Eds., pp. 367–438, Saunders, Philadelphia, Pa, USA, 1992.
- L. G. Mercuri, “Acute osteomyelitis of the jaws,” Oral and Maxillofacial Surgery Clinics of North America, vol. 3, no. 2, p. 355, 1991.
- B. A. Jereczek-Fossa and R. Orecchia, “Radiotherapy-induced mandibular bone complications,” Cancer Treatment Reviews, vol. 28, no. 1, pp. 65–74, 2002.
- T. Reuther, T. Schuster, U. Mende, and A. C. Kübler, “Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients—a report of a thirty year retrospective review,” International Journal of Oral and Maxillofacial Surgery, vol. 32, no. 3, pp. 289–295, 2003.
- M. A. Ben-David, M. Diamante, J. D. Radawski et al., “Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions,” International Journal of Radiation Oncology, Biology and Physics, vol. 68, no. 2, pp. 396–402, 2007.
- American Association of Oral and Maxillofacial Surgeons, “Position paper on bisphosphonate-related osteonecrosis of the jaws,” Journal of Oral and Maxillofacial Surgery, vol. 65, no. 3, pp. 369–376, 2007.
- S. R. Nussbaum, J. Younger, C. J. Vandepol et al., “Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages,” American Journal of Medicine, vol. 95, no. 3, pp. 297–304, 1993.
- E. R. Carlson and J. D. Basile, “The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws,” Journal of Oral and Maxillofacial Surgery, vol. 67, no. 5, supplement, pp. 85–95, 2009.
- C. A. Migliorati, J. Casiglia, J. Epstein, P. L. Jacobsem, M. A. Siegel, and S. B. Woo, “Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper,” Journal of the American Dental Association, vol. 136, no. 12, pp. 1658–1668, 2005.
- R. E. Marx, “Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic,” Journal of Oral and Maxillofacial Surgery, vol. 61, no. 9, pp. 1115–1117, 2003.
- S. Ruggiero, J. Gralow, R. E. Marx, et al., “Practical guidelines for the prevention, diagnosis and treatment of osteonecrosis of the jaw in patients with cancer,” Journal of Oncology Practice, vol. 2, no. 1, pp. 7–14, 2006.
- L. M. Hess, J. M. Jeter, M. Benham-Hutchins, and D. S. Alberts, “Factors associated with osteonecrosis of the jaw among bisphosphonate users,” The American Journal of Medicine, vol. 121, no. 6, pp. 475.e3–483.e3, 2008.
- J. Silvestre-Rangil and F.-J. Silvestre, “Clinico-therapeutic management of osteoradionecrosis: a literature review and update,” Medicina Oral, Patologia Oral y Cirugia Bucal, vol. 16, no. 7, pp. e900–e904, 2011.
- N. Theologie-Lygidakis, O. Schoinohoriti, and I. Iatrou, “Surgical management of primary chronic osteomyelitis of the jaws in children: a prospective analysis of five cases and review of the literature,” Oral and Maxillofacial Surgery, vol. 15, no. 1, pp. 41–50, 2011.
- J. J. Freiberger, “Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws,” Journal of Oral and Maxillofacial Surgery, vol. 67, no. 5, supplement, pp. 96–106, 2009.
- M. Erkan, O. Bilgi, M. Mutluoğlu, and G. Uzun, “Biphosphonate-related osteonecrosis of the jaw in cancer patients and hyperbaric oxygen therapy,” Journal of the Pancreas, vol. 10, no. 5, pp. 579–580, 2009.
- K. Shimura, C. Shimazaki, K. Taniguchi et al., “Hyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonate-induced osteonecrosis of the jaw in a patient with multiple myeloma,” International Journal of Hematology, vol. 84, no. 4, pp. 343–345, 2006.
- M. M. Curi, G. Saraceni Issa Cossolin, D. H. Koga et al., “Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases,” Journal of Oral and Maxillofacial Surgery, vol. 65, no. 2, pp. 349–355, 2007.